Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Addendum
Announcement
Announcements
Author’ response
Author’s reply
Authors' response
Authors#x2019; response
Book Received
Book Review
Book Reviews
Books Received
Centenary Review Article
Clinical Image
Clinical Images
Commentary
Communicable Diseases - Original Articles
Correspondence
Correspondence, Letter to Editor
Correspondences
Correspondences & Authors’ Responses
Corrigendum
Corrrespondence
Critique
Current Issue
Editorial
Editorial Podcast
Errata
Erratum
FORM IV
GUIDELINES
Health Technology Innovation
IAA CONSENSUS DOCUMENT
Innovations
Letter to Editor
Malnutrition & Other Health Issues - Original Articles
Media & News
Notice of Retraction
Obituary
Original Article
Original Articles
Panel of Reviewers (2006)
Panel of Reviewers (2007)
Panel of Reviewers (2009) Guidelines for Contributors
Perspective
Policy
Policy Document
Policy Guidelines
Policy, Review Article
Policy: Correspondence
Policy: Editorial
Policy: Mapping Review
Policy: Original Article
Policy: Perspective
Policy: Process Paper
Policy: Scoping Review
Policy: Special Report
Policy: Systematic Review
Policy: Viewpoint
Practice
Practice: Authors’ response
Practice: Book Review
Practice: Clinical Image
Practice: Commentary
Practice: Correspondence
Practice: Letter to Editor
Practice: Method
Practice: Obituary
Practice: Original Article
Practice: Pages From History of Medicine
Practice: Perspective
Practice: Review Article
Practice: Short Note
Practice: Short Paper
Practice: Special Report
Practice: Student IJMR
Practice: Systematic Review
Pratice, Original Article
Pratice, Review Article
Pratice, Short Paper
Programme
Programme, Correspondence, Letter to Editor
Programme: Authors’ response
Programme: Commentary
Programme: Correspondence
Programme: Editorial
Programme: Original Article
Programme: Originial Article
Programme: Perspective
Programme: Rapid Review
Programme: Review Article
Programme: Short Paper
Programme: Special Report
Programme: Status Paper
Programme: Systematic Review
Programme: Viewpoint
Protocol
Public Notice
Research Brief
Research Correspondence
Retraction
Review Article
Reviewers
Short Paper
Some Forthcoming Scientific Events
Special Opinion Paper
Special Report
Special Section Nutrition & Food Security
Status Paper
Status Report
Strategy
Student IJMR
Systematic Article
Systematic Review
Systematic Review & Meta-Analysis
View Point
Viewpoint
White Paper
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Addendum
Announcement
Announcements
Author’ response
Author’s reply
Authors' response
Authors#x2019; response
Book Received
Book Review
Book Reviews
Books Received
Centenary Review Article
Clinical Image
Clinical Images
Commentary
Communicable Diseases - Original Articles
Correspondence
Correspondence, Letter to Editor
Correspondences
Correspondences & Authors’ Responses
Corrigendum
Corrrespondence
Critique
Current Issue
Editorial
Editorial Podcast
Errata
Erratum
FORM IV
GUIDELINES
Health Technology Innovation
IAA CONSENSUS DOCUMENT
Innovations
Letter to Editor
Malnutrition & Other Health Issues - Original Articles
Media & News
Notice of Retraction
Obituary
Original Article
Original Articles
Panel of Reviewers (2006)
Panel of Reviewers (2007)
Panel of Reviewers (2009) Guidelines for Contributors
Perspective
Policy
Policy Document
Policy Guidelines
Policy, Review Article
Policy: Correspondence
Policy: Editorial
Policy: Mapping Review
Policy: Original Article
Policy: Perspective
Policy: Process Paper
Policy: Scoping Review
Policy: Special Report
Policy: Systematic Review
Policy: Viewpoint
Practice
Practice: Authors’ response
Practice: Book Review
Practice: Clinical Image
Practice: Commentary
Practice: Correspondence
Practice: Letter to Editor
Practice: Method
Practice: Obituary
Practice: Original Article
Practice: Pages From History of Medicine
Practice: Perspective
Practice: Review Article
Practice: Short Note
Practice: Short Paper
Practice: Special Report
Practice: Student IJMR
Practice: Systematic Review
Pratice, Original Article
Pratice, Review Article
Pratice, Short Paper
Programme
Programme, Correspondence, Letter to Editor
Programme: Authors’ response
Programme: Commentary
Programme: Correspondence
Programme: Editorial
Programme: Original Article
Programme: Originial Article
Programme: Perspective
Programme: Rapid Review
Programme: Review Article
Programme: Short Paper
Programme: Special Report
Programme: Status Paper
Programme: Systematic Review
Programme: Viewpoint
Protocol
Public Notice
Research Brief
Research Correspondence
Retraction
Review Article
Reviewers
Short Paper
Some Forthcoming Scientific Events
Special Opinion Paper
Special Report
Special Section Nutrition & Food Security
Status Paper
Status Report
Strategy
Student IJMR
Systematic Article
Systematic Review
Systematic Review & Meta-Analysis
View Point
Viewpoint
White Paper
View/Download PDF

Translate this page into:

Health Technology Innovation
162 (
6
); 910-916
doi:
10.25259/IJMR_1546_2025

Artificial intelligence for screening drug resistance in tuberculosis

Department of Bacteriology, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India
Department of Tuberculosis, Intermediate Reference Laboratory, Chennai, Tamil Nadu, India
Department of Machine Learning, Wadhwani Institute for Artificial Intelligence, New Delhi, India
Division of Communicable Disease , Indian Council of Medical Research, New Delhi, India
Central TB Division, World Health Organization, New Delhi, India
Department of Central TB Division, Ministry of Family and Health Welfare, New Delhi, India
Department of Tuberculosis, Intermediate Reference Laboratory, Hyderabad, Telangana, India
Intermediate Reference Laboratory, State TB Office, Bhopal, India
Department of Tuberculosis Culture & DST Lab, Intermediate Reference Laboratory, Indore, Madhya Pradesh, India
State TB Training & Demonstration Centre & Intermediate Reference Laboratory, Nagpur, Maharashtra, India
Health Department, Intermediate Reference Laboratory, Patna, Bihar, India
Department of Microbiology, Intermediate Reference Laboratory, Lucknow, India
Intermediate Reference Laboratory, Raipur, Chhattisgarh, India
Department of TB Culture and DST Lab, Dr. Sampurnanand Medical College, KN Chest Hospital, Jodhpur, Rajasthan, India
Intermediate Reference Laboratory, Department of Health and Family Welfare, Kolkata, West Bengal, India
National Tuberculosis Institute, Bengaluru, Karnataka, India

For correspondence: Dr Siva Kumar Shanmugam, Department of Bacteriology, ICMR-National Institute for Research in Tuberculosis, Chennai 600 031, Tamil Nadu, India e-mail: shanmugamsiva27@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Abstract

Background & objectives

Central TB division facilitated development of a line probe assay (LPA) artificial intelligence (AI) tool. The tool was developed, trained, and validated for performance by collecting more than 18,000 LPA strips across culture and drug susceptibility Testing (C&DST) laboratories. The Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis (NIRT) evaluated the LPAAI tool independently. The objective was to establish and verify an AI-driven system for automatically interpreting LPA strips, which are employed in tuberculosis drug resistance screening, to improve accuracy, consistency, and scalability across diverse laboratory settings.

Methods

The AI system integrates faster regions convolutional neural network (FR-CNN) for strip detection, detection transformer (DETR) for band localisation, and a hierarchical neural network (HNN) for classification of bands, loci, and drug labels. Independent validation was conducted by ICMR-NIRT using 2810 first-line (FL)-LPA and 241 reflex second-line (SL-LPA) across ten intermediate reference laboratories (IRLs).

Results

AI comparative models demonstrated an accuracy range of 92-100 per cent, with sensitivity between 80-100 per cent and specificity from 86-100 per cent for the tub, rpoB, katG, InhA, gyrA/gyrB,rrs, and eisgenes. The overall F1 score varies from 0.81 to 1.00, indicating perfect precision and recall.

Interpretation & conclusions

This AI system offers a novel, modular architecture capable of expert-level interpretation of LPA strips. The AI tool performs at par with expert readers and offers a reliable, scalable solution for LPA interpretation.AI tool adoption can reduce interpretation time, enhance result uniformity, and improve treatment delivery across India’s TB programme, supporting national goals for TB elimination.

Keywords

Artificial intelligence
DR
TB
hierarchical neural network
line probe assay

Tuberculosis (TB) caused by M. tuberculosis (MTB) is one of the leading causes of death. Globally, 3.2 per cent of individuals with TB were estimated to have multidrug resistant (MDR)/rifampin resistant (RR)-TB among new cases and 16 per cent among previously treated ones in 2024 1. Based on the India TB Report 2024, 5.3 per cent MDR-TB were diagnosed in 2023 2. The End-TB program mandates continued research and development of new tools to fight against the drug resistance of TB at the regional, national, and global levels 1.Currently, under the National Tuberculosis Elimination Program (NTEP), genotypic resistance detection to the first-line (FL) drugs isoniazid (INH) and rifampicin (RIF)and second-line (SL) drugs fluoroquinolone (FQ) and aminoglycosides (AMG) is carried out using line probe assay (LPA) from sputum samples if the patient is smear-positive, and in the case of a smear-negative patient, culture is used 2,3.The principle of LPA involves the identification of probes specific to common mutations (‘mutation probes’) and probes targeting the wild-type sequence (‘wild-type probes’) on a strip4. In FL-LPA, mutations in the katG and inhA genes associated with INH resistance aredetected5. In SL-LPA, mutations in the genes gyrA and gyrB, associated with fluoroquinolone resistance, and the rrs gene associated with aminoglycoside resistance are detected 6,7. Since machine learning (ML), the vital subdomain of artificial intelligence (AI) has been gaining importance in the last two decades8-10, applying it to the interpretation of mutation resistance in LPA could be explored. According to Agrawal et al11 (2024), a reconfigurable AI-based system incorporates Faster Region-based Convolutional Neural Network (Faster R-CNN), Detection Transformer (DETR), and a Hybrid Neural Network (HNN), which was advanced to provide end-to-end interpretation in compliance with World Health Organization (WHO) guidelines and was validated through expert consensus.The LPA AI tool, developed by Wadhwani AI 11, works on the automatic interpretation of results from the scanned LPA sheets by an algorithm. An initial validation study to assess the performance of this tool was carried out at 40 laboratories under the supervision of Central TB division. In this study, the overall accuracy of AI interpretation (2641 FL strips and 340 SL strips) was found to be 97 per cent for RIF, 98 per cent for INH and FLQ, and 99 per cent for kanamycin when compared with manual interpretation 12.

Based on these findings, an independent evaluation of this AI tool was conducted by the Indian Council of Medical Research-National Institute for Research in Tuberculosis (ICMR-NIRT). The aim of this evaluation was to assess the feasibility of using the AI solution in interpretation, time reduction, and enhancement of result consistency across states. We hypothesise that the AI system will achieve results similar to those of trained microbiologists concerning band and drug-level interpretation, concurrently enhancing consistency and decreasing turnaround time within high-throughput diagnostic workflows.

Materials & Methods

The study was conducted at ICMR-NIRT during the year 2023-2024 after obtaining the ethical approval for the study from the Institutional Ethics Committee.

AI interpretation mechanism

A classical computer vision technique (Fig. 1) is applied to identify and extract the strips pasted on the LPA sheet. Our AI pipeline, adapted from automatic interpretation of LPA for tuberculosis (2024) 11, integrates Faster R-CNN for strip detection, DETR for band localisation, and an HNN for band classification. A transformer-based OCR (TrOCR) module is employed to extract patient or sample identifiers from each sheet. Once strips are extracted, as per the deep learning components, a bounding box (BB) is drawn around the band if a band is present in the strip. If two types of objects (foreground and background) are detected, models such as FR-CNN and DETR are applied to customise the architecture. Further, identifying the BB where bands are present, band types such as AC, CC, rpoB-Mut1, etc., are associated with each detected band and its corresponding band type. The BBs estimated by the DETR are sorted, and the relative distances of the centroids of the BBs from a reference are computed. Neural networks were trained using the Adam optimiser. Hyperparameters (such as learning rate, sequence length for long short-term memory (LSTM), batch size, and network depth) were optimised using grid search on the validation split. This forms the positional context for the band prediction model, where a sequence-to-sequence translation is carried out to create a bidirectional LSTM layer. Once band prediction is completed, the band probabilities are sent to the HNN and deterministic rules (DET) to produce drug interpretations. Band-level annotations (bounding boxes, presence/absence) were performed using a custom tool, then validated by multiple microbiologists. Final drug calls were derived either by consensus or deterministic rules applied to the band pattern. Some of the strip results are rejected based on HNN by the rejection classifier and DET and HNN by the discrepancy module. The ambiguous bands are highlighted by the fidelity module (FM) and sent for review by a human in the loop (trained microbiologist) for concordance 11.

Tuberculosis (TB) Line Probe Assay (LPA) Artificial Intelligence (AI) solution uses a deep learning-based computer vision model to automate LPA test interpretation. A Convolutional Neural Network (CNN) detects and classifies bands after preprocessing steps, including image enhancement, alignment correction, and segmentation. The model analyses band presence, position, and intensity to map patterns to wild-type and mutant regions, determining drug resistance. Trained on expert-annotated images, it achieves high accuracy, enabling automated, real-time LPA interpretation within diagnostic workflows.
Fig. 1.
Tuberculosis (TB) Line Probe Assay (LPA) Artificial Intelligence (AI) solution uses a deep learning-based computer vision model to automate LPA test interpretation. A Convolutional Neural Network (CNN) detects and classifies bands after preprocessing steps, including image enhancement, alignment correction, and segmentation. The model analyses band presence, position, and intensity to map patterns to wild-type and mutant regions, determining drug resistance. Trained on expert-annotated images, it achieves high accuracy, enabling automated, real-time LPA interpretation within diagnostic workflows.

Study setting

The validation process by ICMR-NIRT was planned in three different phases:

  1. Phase 1. The LPA sheets at ICMR -NIRT were scanned and interpreted by AI solution.

  2. Phase 2. The LPA sheets from nine Intermediate reference laboratories (IRLs) (at Kolkata, Nagpur, Patna, Raipur, Telangana, Lucknow, Bengaluru, Chennai, and Jodhpur) were scanned using different types of scanners and sent to ICMR-NIRT for AI interpretation.

  3. Phase 3. The LPA sheets that were subjected to scanning and AI interpretation at five IRLs (IRL Lucknow, Hyderabad, Bhopal, Chennai, and Nagpur) were cross-verified by ICMR-NIRT.

AI interpretation and validation

The AI validation conducted by Central TB division initially included 20,000 strips for training the microbiologists at 40 laboratories to perform testing and interpretation independently. Based on the consistency of results obtained, a minimum of 10 per cent of the trained set were included for final evaluation (2000 strips). Based on this calculation and accounting for a 20 per cent contamination rate, the minimum sample size required for this study was 2400 for FL-LPA results and their respective SL-LPA. In phase I, 1945 FL-LPA and 174 SL-LPA results were interpreted and analysed. In Phase II, 865 FL-LPA and 67 SL-LPA, and in Phase III, 271 FL-LPA and 75 SL-LPA, results were included for interpretation and analysis (Fig. 2). The analysis included all the LPA strips with satisfactory internal quality control (IQC) and MTB detection. Sheets with incomplete results or reporting blank/missing interpretations on LPA test results were excluded from the analysis. The minimum scanner specification required for the AI solution is 72 dpi and above; the scanners used in the IRLs across have a range of 260–600 dpi. Three levels of data prediction were used during the analysis; (a) the presence or absence of a band on a given strip; (b) interpretation of gene locus level; (c) the drug level interpretations.

Flow of three phases of Artificial Intelligence First Line (FL)- and Second Line (SL)-Line Probe Assay (LPA) interpretation compared to the gold standard manual reading. Phase I-LPA strips were interpreted and analysed at the Indian Council of Medical Research-National Institute for Research in Tuberculosis (ICMR-NIRT), Phase II-Intermediate Reference Laboratories (IRLs) LPA strips at ICMR-NIRT and, Phase III- at ICMR-NIRT and the five IRLs.
Fig. 2.
Flow of three phases of Artificial Intelligence First Line (FL)- and Second Line (SL)-Line Probe Assay (LPA) interpretation compared to the gold standard manual reading. Phase I-LPA strips were interpreted and analysed at the Indian Council of Medical Research-National Institute for Research in Tuberculosis (ICMR-NIRT), Phase II-Intermediate Reference Laboratories (IRLs) LPA strips at ICMR-NIRT and, Phase III- at ICMR-NIRT and the five IRLs.

Discordance resolution

Microbiologists finalised the discordance resolution by comparing the LPA sheets with the field (nucleic acid amplification test) NAAT results, which is the usual diagnostic flow in FL-LPA interpretation. Such a manual interface is required for AI interpretation of false positives and negative results. The tubband representing MTB positive is considered regardless of its density or faintness. The LPA sheet, consisting of NAAT results obtained from the field, was verified by microbiologists during AI interpretation in the case of false-positive results. Lighter wild (WT) bands and mutant (MUT) bands were verified for false negatives and false positives, respectively, during the manual interface.

Statistical analysis

To assess the effectiveness of the AI model, F1 score13-15, Cohen’s kappa, Fowlkes-Mallows score 16 and Matthew’s correlation coefficient (MCC) 17 were calculated and interpreted against the gold standard. By applying Cohen's Kappa, the agreement between the model's predictions and the gold standard was assessed. F1 Score was chosen to balance precision and recall, critical in minimising both false positives and false negatives in clinical diagnostics. MCC provides a robust, balanced evaluation in imbalanced datasets by incorporating all elements of the confusion matrix. Moreover, area under receiver operating curve (AUROC) reflects overall discriminative power, while area under plotted precision recall curve (AUPRC) is more informative when resistant cases (positive class) are rare, making it particularly relevant for gene-level resistance evaluation. To examine the dependability and resilience of the AI algorithm, the data obtained was analysed using the confusion matrix, ROC, and PRC 18. Respective sensitivity (recall), specificity, accuracy, negative predictive value, positive predictive value (precision), and F1 score, along with the respective AUROC and AUPRCwere obtained. The sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) were calculated to evaluate the performance of the AI model 19.

Results & Discussion

ICMR-NIRT evaluation

FL-LPA (n=1945) and SL-LPA (n=174) were extracted from the LPA sheets from the ICMR-NIRT routine diagnostics. Nine IRLs were included in the study, with a sample size of FL-LPA (n=860) and SL-LPA (n=67), respectively. Out of 174 cases from ICMR-NIRT, SL-LPA reported eight invalids and one indeterminate, while in 1945, FL-LPA strips had three reported invalids

Phase I

The NPV score for the tubband, gyrA/gyrB and rrs genes was 1.00; rpoB, KatG, and InhA were 0.99. The PPV scores for the tubband, rpoB, KatG, InhA, and gyrA/gyrB genes were 0.99-1.00. The accuracy, sensitivity, and specificity were compared for all performances of the tubband and the genes rpoB, katG, InhA, gyrA/gyrB genes, rrs, and eis. The accuracy ranges were as follows: overall (0.92-1.00), sensitivity (0.88-1.00), and specificity (0.86-1.00).The overall F1 score range from 0.89 to 1.00, showcasing ideal precision and recall for all the AI comparative model’s performance at ICMR-NIRT (Table). A scanner with a resolution of 600 dpi was used at ICMR-NIRT to scan the LPA sheets.

Table Comparative performance of the AI model and manual results
Tub, FL-LPA & SL-LPA Accuracy
Sensitivity
Specificity
A B C A B C A B C
Tub detected 0.92 0.99 1.00 1.00 1.00 1.00 0.86 0.98 1.00
rpoB 0.94 0.99 0.98 0.88 0.97 0.94 1.00 1.00 0.99
InhkatG 1.00 0.99 0.97 0.99 0.96 0.90 1.00 1.00 0.98
InhA 0.98 0.99 0.96 0.96 0.80 0.91 1.00 1.00 0.97
gyrA/ gyrB 1.00 1.00 0.88 1.00 1.00 0.97 1.00 1.00 0.82
rrs 1.00 1.00 0.92 0.00 1.00 0.81 0.00 1.00 0.95
eis 1.00 1.00 0.96 0.00 0.00 0.91 0.00 0.00 0.97

A, ICMR-NIRT; B, IRLs at ICMR-NIRT; C, IRLs

Phase II

For the Nine IRLs, specified alone,the NPV and PPV scores range between 0.99 and 1.00. The accuracy varied between 0.99 and 1.00, the sensitivity between 0.80 and 1.00, and the specificity between 0.98 and 1.00 for the tubband and the respective genes. The IRL scanners across had a 260–600 dpi resolution. The F1 score was similar to Phase I, even exhibiting the perfect PR for the AI tool compared with the gold standard.

Phase III

The performance of the AI and manual results at five IRL: NPV ranged from 0.95 to 1.00, and the PPV was 0.78–1.00 for the tubband and the rpoB, KatG, InhA, gyr A, gyrB, and rrs genes. The IRLs demonstrated performance levels ranging from 0.88 to 1.00, with sensitivity from 0.81 to 1.00 and specificity of 0.82 and 1.00 for the corresponding tubband and genes. The overall F1 score ranged from 0.81 to 1.00, showing ideal precision and recall. According to Kuang et al 19 (2022), a high F1 score (close to 1) indicated a balanced trade-off between precision and recall 20 (Supplementary Figure).

Supplementary Figure

Considering the minimum scanner specification required for the solution is 72 dpi and above, the scanners used in the five IRLs (Lucknow, Hyderabad, Bhopal, Chennai, and Nagpur) across had a range of 260–600 dpi (Supplementary Table). Based on the above inference, the scanning performed at IRLs and NRLs did not show any difference in the band density of LPA sheets, though there was a difference in the dpi across.

Supplementary Table

Despite timely outcomes, LPA data interpretation deficiencies persist in many heavily burdened laboratories. Integrating AI-driven systems enhances laboratory workflows for LPA testing, efficiently transmitting data to designated information systems for swift public health interventions. We aim to implement AI-LPA at C&DST laboratories nationwide to achieve the quickest treatment regimen. By utilising an AI solution, this leading study on LPA implementation in India aims to shorten interpretation time and increase the uniformity of the interpretation process across states. The current use of AI and advancements in ubiquitous computing for forecasting respiratory illnesses has opened up a world of potential in the medical industry.

Merged ROC and the PR curve

The AUROC value (0.93–1.00) indicated better model performance for the tubband and the considered genes. The AUPRC value (0.99-1.00) for the tubb and, rpoB, InhA, katG and, gyrA/gyrB genes, indicates perfect precision and recall, while the genes rrs, and eis values (0.50), which cannot classify these respective genes, model performance at ICMR-NIRT. Moreover, the AUROC value (0.98-1.00) demonstrated the enhanced model performance of the discussed genes. The AUPRC values were 1.00 gyrA/gyrB and eis genes, which indicated perfect precision and recall, while the tubband and the genes rpoB, katG, InhA, rrs and eis ranged between (0.98-0.50), which indeed indicated better model performance. The value was 1.00 for the tubb and, indicating perfect discrimination, while the rpoB, katG, InhA, gyrA/gyrB, rrs, and eis ranges (0.88–0.96) represented a better performance model. The AUPRC value ranged from 0.83-0.95 for the rpoB, katG, InhA, gyrA/gyrB, rrs, and eis except the tubband (1.00), which exhibited better model performance for phase III.

Unlike conventional AI systems such as CAD4TB for chest radiographs or CNN-based models for smear microscopy, our system addresses a specific void: the automated analysis of molecular tests using LPA strips. While previous investigations have underscored AI's usefulness in radiology and microscopy, scarce attention has been given to strip-format genetic tests. Thus, our research augments current AI diagnostics by targeting a crucial yet insufficiently automated phase in the drug resistance identification process. Human-in-the-loop review was initiated for 37 per cent of FL-LPA and 32 per cent of SL-LPA strips within the validation dataset; among them, only a small fraction (3–9%) of the total strips called for human correction. Faint bands or visual distortions were the main causes of these overrides, which emphasises the system's durability even as essential quality control is upheld through expert evaluation 11.

The model performs reliably with 72 dpi resolution; however, variability in scanners and imaging conditions may affect consistency. Misclassification can occur due to strip misalignment or artifacts. Additionally, training on a specific dataset may limit generalisability, highlighting the need for broader validation. Successful deployment will require compatible scanners (≥72 dpi) and reliable computing infrastructure, standardised staff training for AI use and override procedures, and adherence to national regulatory and data governance frameworks. Addressing these factors is essential for safe, equitable, and sustainable integration into TB program workflows. Moreover, the system will ensure privacy, mitigate bias, and maintain accountability through anonymised data, diverse training, monitoring, and human-in-the-loop oversight.

Despite its limitations in terms of manual interface, the background analysis has proven AI's overall performance to be superior when manual intervention is applied. A key characteristic of this model is its efficiency in reducing interpretation time and delivering reliable results across states. Future research is expected to predict algorithm optimisation without a manual interface.

Using AI solutions reduces interpretation time and enhances the consistency of the interpretation process across states. Direct transmission allows public health to access the patient's information and help end TB. In this study, we demonstrated that AI-based systems improve laboratory workflows for patient-wise LPA testing and directly transmit information to designated information systems for public health action. The outcomes of this research yielded an exceptional F1 score, illustrating high levels of precision and recall when comparing the AI tool to the gold standards, suggesting a better fit when used along with the manual interface.

Acknowledgment

Late Ms. Dakshayani, Senior Laboratory technician, for her support in the LPA interpretation process.

Financial support & sponsorship

None.

Conflicts of Interest

None.

Use of Artificial Intelligence (AI)-Assisted Technology for manuscript preparation

The authors confirm that there was no use of AI-assisted technology for assisting in the writing of the manuscript and no images were manipulated using AI.

References

  1. . Global tuberculosis report 2024. Geneva: World Health Organization; 2024. Available from: https://iris.who.int/bitstream/handle/10665/379339/9789240101531-eng.pdf?sequence=1, accessed on August 5, 2025.
  2. . India TB report 2024. Delhi: Central TB Division; 2024. Available from: https://tbcindia.gov.in/wp-content/uploads/2024/10/TB-Report_for-Web_08_10-2024-1.pdf, accessed on August 5, 2025.
  3. . The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin. World Health Organization; 2016. Available from: https://www.who.int/tb/publications/molecular-test-resistance/en, accessed on October 5, 2025.
  4. , , , , , , et al. Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis. Clin Chim Acta. 2022;533:183-218.
    [Google Scholar]
  5. , , . Drug resistance patterns and treatment outcomes in DR-TB patients at a tertiary care centre in Mumbai. Indian J Tuberc. 2024;71:S10-4.
    [Google Scholar]
  6. . Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). World Health Organization; 2008. Available from: https://www.stoptb.org/sites/default/files/imported/document/BoardDocs/15/2.08-11_Rolling_out_diagnostics_in_the_field/2.08-11.2_Line_Probe_Assays_0.pdf, accessed on September 5, 2025.
  7. . WHO consolidated guidelines on tuberculosis. 3: diagnosis – rapid diagnostics for tuberculosis detection. Geneva: World Health Organization; 2020. Available from: https://www.who.int/publications/i/item/9789240000339, accessed on September 5, 2025.
  8. , , , , . Machine and deep learning for tuberculosis detection on chest X-rays: Systematic literature review. J Med Internet Res. 2023;25:e43154.
    [Google Scholar]
  9. , , , , , . Artificial intelligence and Machine learning based prediction of resistant and susceptible mutations in Mycobacterium tuberculosis. Sci Rep. 2020;10:5487.
    [Google Scholar]
  10. , , , , , , et al. Application of machine learning techniques to tuberculosis drug resistance analysis. Bioinformatics. 2019;35:2276-82.
    [Google Scholar]
  11. , , , , , , et al. Automatic interpretation of line probe assay test for tuberculosis. AAAI. 2024;38:21897-904.
    [Google Scholar]
  12. . Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians. Available from: https://iris.who.int/bitstream/handle/10665/354240/9789240046665-eng.pdf?sequence=1, accessed on September 5, 2025
  13. , , , , , . Development of machine learning model for diagnostic disease prediction based on laboratory tests. Sci Rep. 2021;11:7567.
    [Google Scholar]
  14. , , , , . Classification model for accuracy and intrusion detection using machine learning approach. Peer J Comput Sci. 2021;7:e437.
    [Google Scholar]
  15. , , . The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Min. 2021;14:13.
    [Google Scholar]
  16. , , , , , , et al. An automated deep learning method for Tile AO/OTA pelvic fracture severity grading from trauma whole-body CT. J Digit Imaging. 2021;34:53-65.
    [Google Scholar]
  17. , , . Evaluation of artificial intelligence on a reference standard based on subjective interpretation. Lancet Digit Health. 2021;3:e693-5.
    [Google Scholar]
  18. , , , , , , et al. Artificial intelligence assisting the early detection of active pulmonary tuberculosis from chest X-rays: a population-based study. Front Mol Biosci. 2022;9:874475.
    [Google Scholar]
  19. , , , , , , et al. Development and clinical validation of Swaasa AI platform for screening and prioritization of pulmonary TB. Sci Rep. 2023;13:4740.
    [Google Scholar]
  20. , , , , . Accurate and rapid prediction of tuberculosis drug resistance from genome sequence data using traditional machine learning algorithms and CNN. Sci Rep. 2022;12:2427.
    [Google Scholar]
Show Sections
Scroll to Top